68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

被引：155
|
作者：
Rauscher, Isabel [1 ,2 ,3 ]
Maurer, Tobias [2 ,4 ]
Fendler, Wolfgang P. [2 ,5 ]
Sommer, Wieland H. [2 ,6 ]
Schwaiger, Markus [1 ,2 ,3 ]
Eiber, Matthias [1 ,2 ,3 ]
机构：
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[2] Clin Canc Ctr Munich CCM, Munich, Germany
[3] German Canc Consortium DKTK, Heidelberg, Germany
[4] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[5] Univ Munich, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[6] Univ Munich, Dept Clin Radiol, Grosshadern Campus,Marchioninistr 15, D-81377 Munich, Germany
来源：
CANCER IMAGING | 2016年 / 16卷
关键词：
Prostate cancer; Prostate specific membrane antigen; Positron emission tomography; GA-68-LABELED PSMA LIGAND; MEMBRANE ANTIGEN; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; LYMPH-NODES; HBED-CC; DIAGNOSIS; EXPRESSION; CARCINOMA; TOMOGRAPHY;
D O I：
10.1186/s40644-016-0072-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging of primary prostate cancer and restaging after biochemical recurrence with Ga-68-PSMA ligand Positron emission tomography/computed tomography (PET/CT). However, prospective trials and clinical guidelines for this new technique are still missing. Therefore, we summarized our experience with Ga-68-PSMA ligand PET/CT examinations in patients with primary PC and biochemical recurrence. It focuses on the technical and logistical aspects of Ga-68-PSMA ligand PET/CT examination as well as on the specific background for image reading discussing also potential pitfalls. Further, it includes relevant issues on free-text as well as structured reporting used in daily clinical routine.
引用
收藏
页数：10
相关论文
共 50 条
  • [21] 68Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer
    Vinsensia, Maria
    Chyoke, Peter L.
    Hadaschik, Boris
    Holland-Letz, Tim
    Moltz, Jan
    Kopka, Klaus
    Rauscher, Isabel
    Mier, Walter
    Schwaiger, Markus
    Haberkorn, Uwe
    Mauer, Tobias
    Kratochwil, Clemens
    Eiber, Matthias
    Giesel, Frederik L.
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (12) : 1949 - 1955
  • [22] 68Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer
    Henkenberens, Christoph
    von Klot, Christoph A.
    Ross, Tobias L.
    Bengel, Frank M.
    Wester, Hans-Juergen
    Merseburger, Axel S.
    Vogel-Claussen, Jens
    Christiansen, Hans
    Derlin, Thorsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (07) : 431 - 439
  • [23] Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer
    Queiroz, Marcelo A.
    Viana, Publio
    Santos, Allan
    Bastos, Diogo
    Etchebehere, Elba
    Cerri, Giovanni
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (09) : E417 - E419
  • [24] 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
    Peter Donato
    Andrew Morton
    John Yaxley
    Sachinka Ranasinghe
    Patrick E. Teloken
    Samuel Kyle
    Geoff Coughlin
    Rachel Esler
    Nigel Dunglison
    Robert A Gardiner
    Matthew J Roberts
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1843 - 1851
  • [25] Correlations of 68Ga-PSMA PET/CT in the initial staging of prostate cancer patients
    Topuz, Ozge Vural
    Aksu, Aysegul
    Erinc, Sadife Ruya
    Tamam, Muge Oner
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2021, 24 (01): : 60 - 65
  • [26] Clinical Impact of Lower-Limb Imaging in 68Ga-PSMA PET/CT for Patients with Prostate Cancer
    Simsek, Duygu Has
    Sanli, Yasemin
    Kuyumcu, Serkan
    Engin, Muge Nur
    Buyukkaya, Fikret
    Demirci, Emre
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2019, 47 (03) : 233 - 237
  • [27] 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
    Cytawa, Wojciech
    Seitz, Anna Katharina
    Kircher, Stefan
    Fukushima, Kazuhito
    Tran-Gia, Johannes
    Schirbel, Andreas
    Bandurski, Tomasz
    Lass, Piotr
    Krebs, Markus
    Polom, Wojciech
    Matuszewski, Marcin
    Wester, Hans-Juergen
    Buck, Andreas K.
    Kuebler, Hubert
    Lapa, Constantin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) : 168 - 177
  • [28] Rectal Carcinoma on 68Ga-PSMA PET/CT
    Huang, Yi-Tung Tom
    Fong, William
    Thomas, Paul
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (03) : E167 - E168
  • [29] Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence
    Bailey, Jason
    Piert, Morand
    CURRENT UROLOGY REPORTS, 2017, 18 (11)
  • [30] Molecular imaging for prostate cancer: Performance analysis of 68Ga-PSMA PET/CT versus choline PET/CT
    Michaud, L.
    Touijer, K. A.
    ACTAS UROLOGICAS ESPANOLAS, 2017, 41 (05): : 292 - 299
12345